(Q39780438)

14 September 2017

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state (English)

1 reference

14 September 2017

1 reference

1 reference

Gustavson LE

1

1 reference

14 September 2017

Kaiser JF

2

1 reference

14 September 2017

Edmonds AL

3

1 reference

14 September 2017

Locke CS

4

1 reference

14 September 2017

DeBartolo ML

5

1 reference

14 September 2017

Schneck DW

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

39

1 reference

14 September 2017

2078-2083

1 reference

14 September 2017

9

1 reference

Eradication of Helicobacter pylori with clarithromycin and omeprazole

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Helicobacter pylori: controversies and an approach to management

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Pharmacokinetic drug interactions of macrolides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Absolute bioavailability of clarithromycin after oral administration in humans

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

The skin in pregnancy--recent advances

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162884

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial

15 June 2018

1 reference

12 December 2020

Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography

1 reference

12 December 2020

Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium

1 reference

12 December 2020

The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics

1 reference

12 December 2020

Helicobacter pylori and peptic ulcer disease

1 reference

12 December 2020

Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Clarithromycin and omeprazole for Helicobacter pylori

1 reference

12 December 2020

Helicobacter pylori and peptic ulcer disease

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.39.9.2078

1 reference

14 September 2017

1 reference

14 September 2017

1 reference